Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

BUY
$1.46 - $2.82 $8 - $16
6 Added 0.04%
16,723 $31,000
Q3 2021

Oct 26, 2021

BUY
$3.81 - $6.76 $49 - $87
13 Added 0.08%
16,717 $64,000
Q2 2021

Aug 03, 2021

BUY
$6.28 - $16.2 $104,901 - $270,604
16,704 New
16,704 $116,000

Others Institutions Holding ONTX

About Onconova Therapeutics, Inc.


  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Hillcrest Wealth Advisors Ny, LLC Portfolio

Follow Hillcrest Wealth Advisors Ny, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillcrest Wealth Advisors Ny, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hillcrest Wealth Advisors Ny, LLC with notifications on news.